Amarin Corp Plc (AMRN): study, thanks for the update. I have che...

Reply Private New

Replies (5) Next 10 Prev Next

Send PM Follow Ignore

Followers	48
Posts	5518
Boards Moderated	0
Alias Born	09/04/2009

ggwpq

Re: studythosestocks post# 373919

Monday, 03/28/2022 5:38:22 PM

Monday, March 28, 2022 5:38:22 PM

study, thanks for the update. I have checked with our very helpful Amarin EVP, Lisa. She has clarified the situation with the following reply:

***

ggwpq,

Can you help me with where you saw this? I’d like to reach out and correct. If it was from the hearing itself I realize it can be confusing so let me try to clarify. This is not a rejection, it is a second ACD request. A second ACD means that the committee was still not able to reach a final recommendation and will require further consultation with stakeholders. The provision of a second ACD is not uncommon for innovative treatments seeking NHS access in the UK. We are encouraged by NICE’s diligent efforts to work alongside us and are driven and determined to have the greatest impact possible on reducing cardiovascular risk for patients. We are confident that by working effectively and proactively through the NICE process we will be able to ensure patients in England are able to access this life-saving medicine.

Hope this helps,

Lisa

***